{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:51:15Z","timestamp":1791654675869,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Investigating the epigenetic mechanisms underlying lung adenocarcinoma (LUAD) through the lens of\n                    <jats:italic>N<\/jats:italic>\n                    4-acetylcytosine (ac4C) modification could innovate cancer treatment strategies and targets. We used biological information methods to analyze shared data, with a focus on studying\n                    <jats:italic>N<\/jats:italic>\n                    -acetyltransferase 10 (NAT10), which is the only known ac4C \u201cwriter\u201d protein. Our analysis revealed a significant upregulation of NAT10 expression in LUAD, a finding that was corroborated by investigations in both LUAD cancer tissue samples and cell lines. Subsequently, we employed CRISPR\/Cas9 technology to knock out the NAT10 gene and analyzed the resulting knockout cells using acRIP-seq and RNA-seq techniques. Our findings demonstrated different expressions of the genes C-X-C motif chemokine ligand 5 (CXCL5) and DEK proto-oncogene (DEK), and functional enrichment analysis indicated a strong association with the adhesion signaling pathway. Laboratory experiments revealed that NAT10 acts as an ac4C \u201cwriter,\u201d promoting the acetylation of\n                    <jats:italic>CXCL5<\/jats:italic>\n                    and\n                    <jats:italic>DEK<\/jats:italic>\n                    and thus preventing the degradation of their mRNAs. Moreover, NAT10 was found to significantly affect the number of metastases and tumor growth following the injection of cancer cells into the tail vein of mice. Our research data suggests that targeting NAT10 has the potential to serve as a diagnostic biomarker or prognostic target for developing anti-metastatic therapies aimed at disrupting the adhesion process.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-08568-6","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T10:45:25Z","timestamp":1774003525000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["NAT10-mediated ac4C RNA acetylation stabilizes CXCL5\/DEK mRNA to drive proliferation and metastasis in lung adenocarcinoma"],"prefix":"10.1038","volume":"17","author":[{"given":"Xin","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boshu","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiheng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5307-2484","authenticated-orcid":false,"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3305-6652","authenticated-orcid":false,"given":"Qiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"8568_CR1","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553:446\u201354.","journal-title":"Nature"},{"key":"8568_CR2","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.jtho.2023.01.088","volume":"18","author":"H Asamura","year":"2023","unstructured":"Asamura H, Nishimura KK, Giroux DJ, Chansky K, Hoering A, Rusch V, et al. IASLC lung cancer staging project: the new database to inform revisions in the ninth edition of the TNM classification of lung cancer. J Thorac Oncol. 2023;18:564\u201375.","journal-title":"J Thorac Oncol"},{"key":"8568_CR3","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","volume":"27","author":"M Wang","year":"2021","unstructured":"Wang M, Herbst RS, Boshoff C. Toward personalized treatment approaches for non-small-cell lung cancer. Nat Med. 2021;27:1345\u201356.","journal-title":"Nat Med"},{"key":"8568_CR4","doi-asserted-by":"crossref","unstructured":"Liu Y, Cheng Z, Zhang J, Zhang Y, Zhao T, Sun L, et al. PSAT1 inhibits mTORC1 activation by preventing Rag heterodimer formation in lung adenocarcinoma. Autophagy. 22:468\u2013483 (2025).","DOI":"10.1080\/15548627.2025.2535765"},{"key":"8568_CR5","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.molcel.2025.03.001","volume":"85","author":"JL Pulice","year":"2025","unstructured":"Pulice JL, Meyerson M. Amplified dosage of the NKX2-1 lineage transcription factor controls its oncogenic role in lung adenocarcinoma. Mol Cell. 2025;85:1311\u20131329.e1316.","journal-title":"Mol Cell"},{"key":"8568_CR6","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/cac2.12523","volume":"44","author":"D Miao","year":"2024","unstructured":"Miao D, Shi J, Lv Q, Tan D, Zhao C, Xiong Z, et al. NAT10-mediated ac(4)C-modified ANKZF1 promotes tumor progression and lymphangiogenesis in clear-cell renal cell carcinoma by attenuating YWHAE-driven cytoplasmic retention of YAP1. Cancer Commun. 2024;44:361\u201383.","journal-title":"Cancer Commun"},{"key":"8568_CR7","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/cac2.12595","volume":"44","author":"H Liu","year":"2024","unstructured":"Liu H, Xu L, Yue S, Su H, Chen X, Liu Q, et al. Targeting N4-acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2-mediated HMGB2 mRNA translation. Cancer Commun. 2024;44:1018\u201341.","journal-title":"Cancer Commun"},{"key":"8568_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06245-6","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wang X, Liu Y, Yang J, Mao W, Feng C, et al. N4-acetylcytidine-dependent GLMP mRNA stabilization by NAT10 promotes head and neck squamous cell carcinoma metastasis and remodels tumor microenvironment through MAPK\/ERK signaling pathway. Cell Death Dis. 2023;14:712.","journal-title":"Cell Death Dis"},{"key":"8568_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2023.113620","volume":"428","author":"G Zong","year":"2023","unstructured":"Zong G, Wang X, Guo X, Zhao Q, Wang C, Shen S, et al. NAT10-mediated AXL mRNA N4-acetylcytidine modification promotes pancreatic carcinoma progression. Exp Cell Res. 2023;428:113620.","journal-title":"Exp Cell Res"},{"key":"8568_CR10","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1101\/gad.2036411","volume":"25","author":"F Kappes","year":"2011","unstructured":"Kappes F, Waldmann T, Mathew V, Yu J, Zhang L, Khodadoust MS, et al. The DEK oncoprotein is a Su(var) that is essential to heterochromatin integrity. Genes Dev. 2011;25:673\u20138.","journal-title":"Genes Dev"},{"key":"8568_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1101\/gad.1857410","volume":"24","author":"S Sawatsubashi","year":"2010","unstructured":"Sawatsubashi S, Murata T, Lim J, Fujiki R, Ito S, Suzuki E, et al. A histone chaperone, DEK, transcriptionally coactivates a nuclear receptor. Genes Dev. 2010;24:159\u201370.","journal-title":"Genes Dev"},{"key":"8568_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01145-0","volume":"14","author":"MA Hopper","year":"2024","unstructured":"Hopper MA, Dropik AR, Walker JS, Novak JP, Laverty MS, Manske MK, et al. DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas. Blood Cancer J. 2024;14:172.","journal-title":"Blood Cancer J"},{"key":"8568_CR13","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3892\/ol.2021.12701","volume":"21","author":"MQ Yang","year":"2021","unstructured":"Yang MQ, Bai LL, Wang Z, Lei L, Zheng YW, Li ZH, et al. DEK is highly expressed in breast cancer and is associated with malignant phenotype and progression. Oncol Lett. 2021;21:440.","journal-title":"Oncol Lett"},{"key":"8568_CR14","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1038\/onc.2014.173","volume":"34","author":"LM Privette Vinnedge","year":"2015","unstructured":"Privette Vinnedge LM, Benight NM, Wagh PK, Pease NA, Nashu MA, Serrano-Lopez J, et al. The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor-positive breast cancers. Oncogene. 2015;34:2325\u201336.","journal-title":"Oncogene"},{"key":"8568_CR15","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3892\/or.2017.5721","volume":"38","author":"X Xu","year":"2017","unstructured":"Xu X, Zou L, Yao Q, Zhang Y, Gan L, Tang L. Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK\/p-Ser9-GSK-3\u03b2\/p-Tyr216-GSK-3\u03b2\/\u03b2-catenin axis. Oncol Rep. 2017;38:1035\u201342.","journal-title":"Oncol Rep"},{"key":"8568_CR16","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","volume":"36","author":"A Zlotnik","year":"2012","unstructured":"Zlotnik A, Yoshie O. The chemokine superfamily revisited. Immunity. 2012;36:705\u201316.","journal-title":"Immunity"},{"key":"8568_CR17","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.ejca.2006.01.006","volume":"42","author":"RM Strieter","year":"2006","unstructured":"Strieter RM, Burdick MD, Mestas J, Gomperts B, Keane MP, Belperio JA. Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer. 2006;42:768\u201378.","journal-title":"Eur J Cancer"},{"key":"8568_CR18","doi-asserted-by":"crossref","unstructured":"Matsuo K, Yoshie O, Nakayama T. Multifaceted roles of chemokines and chemokine receptors in tumor immunity. Cancers 13, 6132 (2021).","DOI":"10.3390\/cancers13236132"},{"key":"8568_CR19","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1158\/1078-0432.CCR-18-3567","volume":"25","author":"Z Zhou","year":"2019","unstructured":"Zhou Z, Xia G, Xiang Z, Liu M, Wei Z, Yan J, et al. A C-X-C chemokine receptor type 2-dominated cross-talk between tumor cells and macrophages drives gastric cancer metastasis. Clin Cancer Res. 2019;25:3317\u201328.","journal-title":"Clin Cancer Res"},{"key":"8568_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0629-4","volume":"16","author":"J Zhao","year":"2017","unstructured":"Zhao J, Ou B, Han D, Wang P, Zong Y, Zhu C, et al. Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK\/Elk-1\/Snail and AKT\/GSK3\u03b2\/\u03b2-catenin pathways. Mol Cancer. 2017;16:70.","journal-title":"Mol Cancer"},{"key":"8568_CR21","doi-asserted-by":"publisher","first-page":"5927","DOI":"10.1158\/0008-5472.CAN-18-1702","volume":"78","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Shurin GV, Zhong H, Bunimovich YL, Han B, Shurin MR. Schwann cells augment cell spreading and metastasis of lung cancer. Cancer Res. 2018;78:5927\u201339.","journal-title":"Cancer Res"},{"key":"8568_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.canlet.2018.10.027","volume":"442","author":"Y Peng","year":"2019","unstructured":"Peng Y, Kajiyama H, Yuan H, Nakamura K, Yoshihara M, Yokoi A, et al. PAI-1 secreted from metastatic ovarian cancer cells triggers the tumor-promoting role of the mesothelium in a feedback loop to accelerate peritoneal dissemination. Cancer Lett. 2019;442:181\u201392.","journal-title":"Cancer Lett"},{"key":"8568_CR23","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.cell.2018.10.030","volume":"175","author":"D Arango","year":"2018","unstructured":"Arango D, Sturgill D, Alhusaini N, Dillman AA, Sweet TJ, Hanson G, et al. Acetylation of cytidine in mRNA promotes translation efficiency. Cell. 2018;175:1872\u20131886.e1824.","journal-title":"Cell"},{"key":"8568_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3570-4","volume":"17","author":"Q Li","year":"2017","unstructured":"Li Q, Liu X, Jin K, Lu M, Zhang C, Du X, et al. NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activity. BMC Cancer. 2017;17:605.","journal-title":"BMC Cancer"},{"key":"8568_CR25","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.2147\/OTT.S156582","volume":"11","author":"ZX Zhang","year":"2018","unstructured":"Zhang ZX, Zhang WN, Sun YY, Li YH, Xu ZM, Fu WN. CREB promotes laryngeal cancer cell migration via MYCT1\/NAT10 axis. Onco Targets Ther. 2018;11:1323\u201331.","journal-title":"Onco Targets Ther"},{"key":"8568_CR26","doi-asserted-by":"publisher","first-page":"100783","DOI":"10.1016\/j.tranon.2020.100783","volume":"13","author":"Y Cao","year":"2020","unstructured":"Cao Y, Yao M, Wu Y, Ma N, Liu H, Zhang B. N-Acetyltransferase 10 promotes micronuclei formation to activate the senescence-associated secretory phenotype machinery in colorectal cancer cells. Transl Oncol. 2020;13:100783.","journal-title":"Transl Oncol"},{"key":"8568_CR27","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/cac2.12363","volume":"42","author":"X Zheng","year":"2022","unstructured":"Zheng X, Wang Q, Zhou Y, Zhang D, Geng Y, Hu W, et al. N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA. Cancer Commun. 2022;42:1347\u201366.","journal-title":"Cancer Commun"},{"key":"8568_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42135-3","volume":"14","author":"Q Yan","year":"2023","unstructured":"Yan Q, Zhou J, Wang Z, Ding X, Ma X, Li W, et al. NAT10-dependent N(4)-acetylcytidine modification mediates PAN RNA stability, KSHV reactivation, and IFI16-related inflammasome activation. Nat Commun. 2023;14:6327.","journal-title":"Nat Commun"},{"key":"8568_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13046-022-02586-w","volume":"42","author":"M Deng","year":"2023","unstructured":"Deng M, Zhang L, Zheng W, Chen J, Du N, Li M, et al. Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression. J Exp Clin Cancer Res. 2023;42:9.","journal-title":"J Exp Clin Cancer Res"},{"key":"8568_CR30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41392-021-00489-4","volume":"6","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Jing Y, Wang Y, Tang J, Zhu X, Jin WL, et al. NAT10 promotes gastric cancer metastasis via N4-acetylated COL5A1. Signal Transduct Target Ther. 2021;6:173.","journal-title":"Signal Transduct Target Ther"},{"key":"8568_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06373-z","volume":"15","author":"Y Shuai","year":"2024","unstructured":"Shuai Y, Zhang H, Liu C, Wang J, Jiang Y, Sun J, et al. CLIC3 interacts with NAT10 to inhibit N4-acetylcytidine modification of p21 mRNA and promote bladder cancer progression. Cell Death Dis. 2024;15:9.","journal-title":"Cell Death Dis"},{"key":"8568_CR32","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1016\/j.molcel.2022.05.016","volume":"82","author":"D Arango","year":"2022","unstructured":"Arango D, Sturgill D, Yang R, Kanai T, Bauer P, Roy J, et al. Direct epitranscriptomic regulation of mammalian translation initiation through N4-acetylcytidine. Mol Cell. 2022;82:2797\u20132814.e2711.","journal-title":"Mol Cell"},{"key":"8568_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.ade1119","volume":"17","author":"IY Hwang","year":"2024","unstructured":"Hwang IY, Kim JS, Harrison KA, Park C, Shi CS, Kehrl JH. Chemokine-mediated F-actin dynamics, polarity, and migration in B lymphocytes depend on WNK1 signaling. Sci Signal. 2024;17:eade1119.","journal-title":"Sci Signal"},{"key":"8568_CR34","doi-asserted-by":"crossref","unstructured":"Hong KO, Ahn CH, Yang IH, Han JM, Shin JA, Cho SD, et al. Norcantharidin suppresses YD-15 cell invasion through inhibition of FAK\/paxillin and F-actin reorganization. Molecules. 24, 1928 (2019).","DOI":"10.3390\/molecules24101928"},{"key":"8568_CR35","doi-asserted-by":"crossref","unstructured":"Shi L, Zhang M, Yang H, Li X, He S, Chu Y, et al. NAT10 regulates heart development and function by maintaining the expression of genes related to fatty acid \u03b2-oxidation and heart contraction. Cell Death Differ. 33, 358\u2013373 (2025).","DOI":"10.1038\/s41418-025-01577-6"},{"key":"8568_CR36","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1038\/s41556-024-01548-y","volume":"26","author":"S Zhang","year":"2024","unstructured":"Zhang S, Huang F, Wang Y, Long Y, Li Y, Kang Y, et al. NAT10-mediated mRNA N(4)-acetylcytidine reprograms serine metabolism to drive leukaemogenesis and stemness in acute myeloid leukaemia. Nat Cell Biol. 2024;26:2168\u201382.","journal-title":"Nat Cell Biol"},{"key":"8568_CR37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2418409122","volume":"122","author":"JN Wang","year":"2025","unstructured":"Wang JN, Suo XG, Yu JT, Luo QC, Ji ML, Zhang MM, et al. NAT10 exacerbates acute renal inflammation by enhancing N4-acetylcytidine modification of the CCL2\/CXCL1 axis. Proc Natl Acad Sci USA. 2025;122:e2418409122.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8568_CR38","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/eurheartj\/ehae707","volume":"46","author":"C Yu","year":"2025","unstructured":"Yu C, Chen Y, Luo H, Lin W, Lin X, Jiang Q, et al. NAT10 promotes vascular remodelling via mRNA ac4C acetylation. Eur Heart J. 2025;46:288\u2013304.","journal-title":"Eur Heart J"},{"key":"8568_CR39","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1093\/nar\/gkaa130","volume":"48","author":"HY Liu","year":"2020","unstructured":"Liu HY, Liu YY, Yang F, Zhang L, Zhang FL, Hu X, et al. Acetylation of MORC2 by NAT10 regulates cell-cycle checkpoint control and resistance to DNA-damaging chemotherapy and radiotherapy in breast cancer. Nucleic Acids Res. 2020;48:3638\u201356.","journal-title":"Nucleic Acids Res"},{"key":"8568_CR40","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1016\/j.apsb.2022.01.015","volume":"12","author":"R Wei","year":"2022","unstructured":"Wei R, Cui X, Min J, Lin Z, Zhou Y, Guo M, et al. NAT10 promotes cell proliferation by acetylating CEP170 mRNA to enhance translation efficiency in multiple myeloma. Acta Pharm Sin B. 2022;12:3313\u201325.","journal-title":"Acta Pharm Sin B"},{"key":"8568_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05944-4","volume":"14","author":"C Xu","year":"2023","unstructured":"Xu C, Yang K, Xuan Z, Li J, Liu Y, Zhao Y, et al. BCKDK regulates breast cancer cell adhesion and tumor metastasis by inhibiting TRIM21 ubiquitinate talin1. Cell Death Dis. 2023;14:445.","journal-title":"Cell Death Dis"},{"key":"8568_CR42","doi-asserted-by":"publisher","first-page":"103502","DOI":"10.1016\/j.critrevonc.2021.103502","volume":"167","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhang Y, Ding Y, Zhuang R. Platelet-mediated tumor metastasis mechanism and the role of cell adhesion molecules. Crit Rev Oncol Hematol. 2021;167:103502.","journal-title":"Crit Rev Oncol Hematol"},{"key":"8568_CR43","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature06188","volume":"449","author":"AE Karnoub","year":"2007","unstructured":"Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature. 2007;449:557\u201363.","journal-title":"Nature"},{"key":"8568_CR44","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.molp.2023.04.009","volume":"16","author":"B Li","year":"2023","unstructured":"Li B, Li D, Cai L, Zhou Q, Liu C, Lin J, et al. Transcriptome-wide profiling of RNA N(4)-cytidine acetylation in Arabidopsis thaliana and Oryza sativa. Mol Plant. 2023;16:1082\u201398.","journal-title":"Mol Plant"},{"key":"8568_CR45","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31\u201346.","journal-title":"Cancer Discov"},{"key":"8568_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc2748","volume":"10","author":"JS Desgrosellier","year":"2010","unstructured":"Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer. 2010;10:9\u201322.","journal-title":"Nat Rev Cancer"},{"key":"8568_CR47","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","volume":"149","author":"KD Meyer","year":"2012","unstructured":"Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE, Jaffrey SR. Comprehensive analysis of mRNA methylation reveals enrichment in 3\u2019 UTRs and near stop codons. Cell. 2012;149:1635\u201346.","journal-title":"Cell"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08568-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08568-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08568-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:02:58Z","timestamp":1774987378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08568-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8568"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08568-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"12 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. All animal research adhered to institutional ethical standards (IACUC-2023078). Samples of three pairs of LUAD tissues along with their nearby normal tissue specimens were randomly obtained from the Second Affiliated Hospital of Harbin Medical University. The collection of these samples was authorized by the Institutional Ethics Committee for future extraction and analysis (HIT-2023050). We stated that informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"326"}}